Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "DESTINY-Breast04 Study Updated Survival Results - T-DXd vs. Treatment of Physician’s Choice in Patients With HER2-Low Unresectable and/or Metastatic Breast Cancer"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Shanu Modi
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Shanu Modi
331 views
November 3, 2023
Comments 0
Login to view comments.
Click here to Login
Breast